Table 1.
Characteristic | Median (Range) or n (%) |
---|---|
Age (years) | 50 (35 – 65) |
Initial tumor size (cm)* | 5.2 (2.7 to 10.3) |
Histologic Type: | |
Invasive ductal | 13 (93%) |
Invasive lobular | 1 (7%) |
Tumor Gradea: | |
1 | 1 (7%) |
2 | 1 (7%) |
3 | 12 (86%) |
ER | |
Positive | 6 (43%) |
Negative | 8 (57%) |
PR | |
Positive | 3 (21%) |
Negative | 11 (79%) |
HER-2/neu | |
Positive | 4 (29%) |
Negative | 10 (71%) |
Pathologic Response | |
Complete | 5 (36%) |
Residual Disease | 9 (64%) |
Abbreviations: ER, estrogen receptor; PR, progesterone receptor
Size measured for largest tumor diameter on DCE-MRI.
Tumor grade was assessed prior to treatment